Unknown

Dataset Information

0

FAM129B is a novel regulator of Wnt/?-catenin signal transduction in melanoma cells.


ABSTRACT: The inability of targeted BRAF inhibitors to produce long-lasting improvement in the clinical outcome of melanoma highlights a need to identify additional approaches to inhibit melanoma growth. Recent studies have shown that activation of the Wnt/?-catenin pathway decreases tumor growth and cooperates with ERK/MAPK pathway inhibitors to promote apoptosis in melanoma. Therefore, the identification of Wnt/?-catenin regulators may advance the development of new approaches to treat this disease. In order to move towards this goal we performed a large scale small-interfering RNA (siRNA) screen for regulators of ?-catenin activated reporter activity in human HT1080 fibrosarcoma cells. Integrating large scale siRNA screen data with phosphoproteomic data and bioinformatics enrichment identified a protein, FAM129B, as a potential regulator of Wnt/?-catenin signaling.  Functionally, we demonstrated that siRNA-mediated knockdown of FAM129B in A375 and A2058 melanoma cell lines inhibits WNT3A-mediated activation of a ?-catenin-responsive luciferase reporter and inhibits expression of the endogenous Wnt/?-catenin target gene, AXIN2. We also demonstrate that FAM129B knockdown inhibits apoptosis in melanoma cells treated with WNT3A. These experiments support a role for FAM129B in linking Wnt/?-catenin signaling to apoptosis in melanoma.

SUBMITTER: Conrad W 

PROVIDER: S-EPMC3829391 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications


The inability of targeted BRAF inhibitors to produce long-lasting improvement in the clinical outcome of melanoma highlights a need to identify additional approaches to inhibit melanoma growth. Recent studies have shown that activation of the Wnt/β-catenin pathway decreases tumor growth and cooperates with ERK/MAPK pathway inhibitors to promote apoptosis in melanoma. Therefore, the identification of Wnt/β-catenin regulators may advance the development of new approaches to treat this disease. In  ...[more]

Similar Datasets

| S-EPMC7353137 | biostudies-literature
| S-EPMC7200158 | biostudies-literature
| S-EPMC2908610 | biostudies-literature
| S-EPMC4977476 | biostudies-literature
| S-EPMC2781415 | biostudies-literature
| S-EPMC3693007 | biostudies-literature
| S-EPMC5348391 | biostudies-other
| S-EPMC5643146 | biostudies-literature
| S-EPMC1219034 | biostudies-other
| S-EPMC6359839 | biostudies-other